Background: Central line-associated bloodstream infection (CLABSI) is a preventable complication of central venous catheters (CVC) that can result in prolonged hospitalization, increased cost, and mortality.
Local Problem: CLABSI rates in a solid organ transplant unit were above the National Database of Nursing Quality Indicators target.
Methods: Evidence-based CLABSI prevention interventions were implemented using the Plan-Do-Study-Act process.
Interventions: A stepwise approach was used to implement CVC maintenance bundle pole cards, chlorhexidine gluconate (CHG) bathing treatments, and Kamishibai card (K-card) door tag processes for all patients with CVCs.
Results: The unit achieved and sustained >90% compliance with both CHG bathing treatments and K-card door tag processes. The CLABSI rate decreased from 2.15 to 0.41, an 81% reduction.
Conclusions: CLABSI reduction in a transplant unit can be achieved through the systematic implementation of evidence-based practices.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/NCQ.0000000000000854 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Frequency of Culture-proven Bacterial Infection and Radiographic Pneumonia in Pediatric Heart Transplant Recipients.
Pediatr Infect Dis J
March 2025
Divisions of Pediatric Emergency Medicine and Pediatric Infectious Diseases, Baylor College of Medicine, Houston, Texas.
Background: Infection is a leading cause of death after pediatric heart transplants (PHTs). Understanding of common pathogens is needed to guide testing strategies and empiric antibiotic use.
Methods: We conducted a 3-center retrospective study of PHT recipients ≤18 years old presenting to cardiology clinics or emergency departments (EDs) from 2010 to 2018 for evaluation of suspected infections within 2 years of transplant.
Reduction of Central Line-Associated Bloodstream Infections on a Transplant Unit.
J Nurs Care Qual
March 2025
Author Affiliations: Director Patient Care-Oncology, Surgery, & Transplant Services, Emory University Hospital, Atlanta, GA (Ms Spinks); Solid Organ Transplant, Unit Nurse Educator, Emory University Hospital, Atlanta, GA (Ms Berhanu); Solid Organ Transplant, Education Coordinator, Emory University Hospital, Atlanta, GA (Mr Buenvenida); Solid Organ Transplant, Unit Director, Emory University Hospital, Atlanta, GA (Ms Henry); Division of Transplantation, Emory University School of Medicine, Atlanta, GA (Dr Lo); and Infection Preventionist, Infection Prevention and Control Department, Emory University Hospital, Atlanta, GA (Dr Yun).
Background: Central line-associated bloodstream infection (CLABSI) is a preventable complication of central venous catheters (CVC) that can result in prolonged hospitalization, increased cost, and mortality.
Local Problem: CLABSI rates in a solid organ transplant unit were above the National Database of Nursing Quality Indicators target.
Methods: Evidence-based CLABSI prevention interventions were implemented using the Plan-Do-Study-Act process.
Individualized Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 10% Administration in Chronic Inflammatory Demyelinating Polyradiculoneuropathy: The Nurse's Role.
J Infus Nurs
March 2025
Author Affiliations: Takeda Development Center Americas, Inc., Cambridge, Massachusetts (Kim Duff); IQVIA Clinical Research Organization, Milan, Italy (Arianna Soresini); IQVIA Clinical Research Organization, Cambridge, Massachusetts (Nancy Wolf* and Alane Fairchild); IQVIA Clinical Research Organization, Ankara, Turkey (Şükran Altan**); IQVIA Clinical Research Organization, Mexico City, Mexico (Wendy Bencomo); University Clinical Center of Serbia, Belgrade, Serbia (Ivana Ivankovic); University Health Network, University of Toronto, Toronto, Ontario, Canada (Evelyn Sarpong); IQVIA Clinical Research Organization, Warsaw, Poland (Anna Kuczkowska).
Hyaluronidase-facilitated subcutaneous immunoglobulin (fSCIG) 10% offers potential improvements in patient independence and tolerability versus intravenous immunoglobulin (IVIG) when used for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). fSCIG 10% also requires less frequent infusions and fewer infusion sites than conventional subcutaneous immunoglobulin (subcutaneous immunoglobulin without hyaluronidase). The ADVANCE-CIDP 1 study demonstrated fSCIG 10% efficacy and safety in preventing CIDP relapse and positive responses from patients in terms of satisfaction and treatment preference.
View Article and Find Full Text PDFHemoadsorption and plasma adsorption: two current options for the 3rd dimension of dialysis purification.
J Nephrol
March 2025
Nephrology Dialysis and Kidney Transplant Unit, Azienda Ospedaliero Universitaria di Modena, Via del pozzo 71, 41122, Modena, Italy.
The adsorption technique has opened a new frontier in the field of purification through hemodialysis. This technique has proved to be effective in removing uremic toxins previously deemed inaccessible due to their size or charge, as well as to their molecular interactions with blood proteins. In this context, this review provides a detailed explanation of the role of Polyester-polymer alloy (PEPA®) membranes and hemodiafiltration with endogenous reinfusion.
View Article and Find Full Text PDFAdjuvant treatment with Capecitabine in patients who received orthotopic liver transplantation with incidental diagnosis of intrahepatic cholangiocarcinoma. Implications on DPYD polymorphisms assessment: report of two cases and review of the literature.
Cancer Chemother Pharmacol
March 2025
Medical Oncology, Department of Clinical and Molecular Sciences, University Politecnica delle Marche, Ancona, 60126, Italy.
In recent years, assessing dihydropyrimidine dehydrogenase (DPD) activity has become crucial for cancer patients undergoing 5-fluorouracil (5FU)-based chemotherapy due to the life-threatening toxicity associated with reduced DPD function. The methods for evaluating DPD activity have evolved, with the analysis of DPYD polymorphisms in blood samples becoming the preferred approach. As the indications for liver transplantation are increasing-particularly due to a rise in cases of cholangiocarcinoma (CCA) and non-resectable colorectal liver metastasis-more cancer patients with a history of liver transplantation may experience disease relapse.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!